272 Participants Needed

Web-Based App for Sickle Cell Disease

SP
MP
Overseen ByMargie Prentice, MBA
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Medical University of South Carolina
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Web-Based App for Sickle Cell Disease?

Research shows that using digital educational tools can improve patient knowledge and self-management in chronic conditions like sickle cell disease. For example, eHealth tools have been reported to enhance health literacy and quality of life for patients with sickle cell disease, and innovative educational methods have been shown to improve knowledge and reduce hospitalizations.12345

Is the web-based app for sickle cell disease safe for humans?

There is no specific safety data available for the web-based app for sickle cell disease or its related names. However, similar digital tools like the 'Safe Patients' app have been used to increase patient knowledge about safety issues, suggesting that educational apps can be safely implemented in healthcare settings.678910

How does the web-based app for sickle cell disease differ from other treatments?

The web-based app for sickle cell disease is unique because it focuses on self-management by allowing patients to track symptoms and health history through a mobile platform. This approach empowers patients and their families to manage the condition more effectively at home, which is different from traditional treatments that primarily rely on medical interventions.1112131415

What is the purpose of this trial?

The purpose of this study is to find out whether a web-based intervention using a mobile app is helpful for teens and young adults with sickle cell disease (SCD) in learning how to care for and manage their symptoms.

Eligibility Criteria

This trial is for teens and young adults with any type of Sickle Cell Disease who own a mobile device compatible with the app, have internet access, and can understand English. It's not for those planning to move or transition to adult care soon, or with neurocognitive issues affecting their ability to participate.

Inclusion Criteria

Owns mobile device compatible with the intervention
Documentation in the electronic health record of any type of SCD
Access to the internet

Exclusion Criteria

Non-English speaking
You have difficulty thinking or understanding things, which may make it hard for you to use the treatment or take part in the study.
Plans to relocate outside of study site area in the next 12 months
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive a web-based intervention using a mobile app to facilitate self-management behaviors

9 months
Ongoing virtual engagement

Control

Participants receive enhanced usual care as a control group

9 months
Ongoing virtual engagement

Follow-up

Participants are monitored for self-management behaviors, quality of life, and healthcare utilization

3 months

Treatment Details

Interventions

  • Electronic educational materials
  • Voice Crisis Alert V2
Trial Overview The study is testing if a web-based mobile app called Voice Crisis Alert V2 along with electronic educational materials can help manage sickle cell disease by teaching patients about symptom care.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Study participants randomized to receive the intervention.
Group II: ControlActive Control1 Intervention
Study participants randomized to receive enhanced usual care (control).

Find a Clinic Near You

Who Is Running the Clinical Trial?

Medical University of South Carolina

Lead Sponsor

Trials
994
Recruited
7,408,000+

National Institute of Nursing Research (NINR)

Collaborator

Trials
623
Recruited
10,400,000+

Findings from Research

The University of South Alabama Children's & Women's Hospital implemented a new patient and family education program that provides tablet computers for accessing reliable health resources, enhancing understanding for families of children newly diagnosed with cancer and chronic illnesses.
Surveys were created to evaluate the effectiveness of these educational interventions, indicating a structured approach to improving patient and family education during critical treatment periods.
Tablet Computer Use at the Bedside in a New Patient/Family Education Program.Fenske, RF.[2020]
The open access mobile app for patient education on orthopedic injuries was downloaded 725 times and viewed over 9,000 times in 34 months, indicating strong interest and engagement among users.
Most users (55%) found the app helpful, and 78% would recommend it, although older patients (over 55 years) showed significantly lower participation rates, highlighting a potential gap in accessibility for this age group.
Enhancing Trauma Patient Experience Through Education and Engagement: Development of a Mobile Application.Childs, BR., Breslin, MA., Andres, BA., et al.[2022]
A pilot study involving 713 adult patients in a respiratory medicine department showed that using audio recordings for patient education significantly increased patient satisfaction compared to traditional methods.
Asthma patients who received audio education spent less time in face-to-face communication while achieving higher feedback rates, suggesting that audio materials can effectively enhance patient understanding and alleviate the burden on nursing staff.
Application of Audio Education in Respiratory Medicine Wards.Zhao, Y., Liu, M., Fan, Z., et al.[2021]

References

Tablet Computer Use at the Bedside in a New Patient/Family Education Program. [2020]
Enhancing Trauma Patient Experience Through Education and Engagement: Development of a Mobile Application. [2022]
Application of Audio Education in Respiratory Medicine Wards. [2021]
Exploring the Challenges and Opportunities of eHealth Tools for Patients with Sickle Cell Disease. [2018]
Empowering patients with sickle cell anemia and their families through innovative educational methods. [2023]
Using automated text messages to monitor adverse events following immunisation in general practice. [2022]
Modeling an IT Support for Handling Serious Adverse Events in Clinical Trials. [2018]
Assessment of attitudes towards adverse events following immunization with oral poliovirus vaccine: a pilot study among high school students of Kinshasa, the Democratic Republic of Congo. [2022]
Effects of the Smartphone Application "Safe Patients" on Knowledge of Patient Safety Issues Among Surgical Patients. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Identifying patients with post-discharge care problems using an interactive voice response system. [2021]
Educational technology on COVID-19 for families of children and adolescents with sickle cell disease. [2021]
12.United Statespubmed.ncbi.nlm.nih.gov
Development and evaluation of iManage: A self-management app co-designed by adolescents with sickle cell disease. [2022]
Feasibility of an mHealth self-management intervention for children and adolescents with sickle cell disease and their families. [2022]
Preferences for Using a Mobile App in Sickle Cell Disease Self-management: Descriptive Qualitative Study. [2022]
15.United Statespubmed.ncbi.nlm.nih.gov
Usability testing of a Smartphone for accessing a web-based e-diary for self-monitoring of pain and symptoms in sickle cell disease. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security